| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 10 4720-4728, Copyright © 1997 by American Association of Immunologists
ARTICLES |
SK Chai, GL Nichols and P Rothman
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York 10032, USA.
An important step in the oncogenic transformation of hemopoietic cells and the subsequent development of leukemia is the proliferation of tumor cells in the absence of exogenous growth factors. In most cases of chronic myelocytic leukemia and in some cases of acute myelocytic leukemia and acute lymphocytic leukemia, the bcr-abl oncogene is involved in this process. Although the BCR-Abl oncoprotein demonstrates enhanced tyrosine kinase activity in leukemic cells, the mechanism by which this leads to growth factor independence remains poorly defined. One proposed mechanism is the activation of cytokine signal transduction pathways, possibly by an autocrine loop involving IL-3 and/or granulocyte-macrophage CSF. Examination of several different cell lines expressing BCR-Abl demonstrates that some of these cells have constitutive activation of the JAK/STAT signaling pathway. We have found the constitutive activation of STAT5 in most, but not all, cell lines expressing BCR-Abl. This constitutive activation of STAT5 is variably associated with a corresponding activation of JAK kinases. Ab blocking studies show that the activation of STAT5 in these cell lines cannot be attributed to the activation of an IL-3/granulocyte- macrophage CSF-driven autocrine loop. Interestingly, samples of peripheral blood cells derived from patients with acute myelocytic leukemia and chronic myelocytic leukemia, which express BCR-Abl, demonstrate constitutive activation of STAT family members. These studies suggest that in a variety of leukemic states, BCR-Abl may use a bypass mechanism to activate cytokine signal transduction pathways.
This article has been cited by other articles:
|
|
 |
|
  S. Okabe, T. Tauchi, and K. Ohyashiki Characteristics of Dasatinib- and Imatinib-Resistant Chronic Myelogenous Leukemia Cells Clin. Cancer Res., October 1, 2008; 14(19): 6181 - 6186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ferrajoli, S. Faderl, Q. Van, P. Koch, D. Harris, Z. Liu, I. Hazan-Halevy, Y. Wang, H. M. Kantarjian, W. Priebe, et al. WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells Cancer Res., December 1, 2007; 67(23): 11291 - 11299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yan, J.-K. Luo, K. J. Ritchie, I. Sakai, K. Takeuchi, R. Ren, and D.-E. Zhang Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling Blood, July 1, 2007; 110(1): 305 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Thomas Philadelphia Chromosome Positive Acute Lymphocytic Leukemia: A New Era of Challenges Hematology, January 1, 2007; 2007(1): 435 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Kantarjian, M. Talpaz, F. Giles, S. O'Brien, and J. Cortes New Insights into the Pathophysiology of Chronic Myeloid Leukemia and Imatinib Resistance Ann Intern Med, December 19, 2006; 145(12): 913 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wetzler, M. T. Brady, E. Tracy, Z.-R. Li, K. A. Donohue, K. L. O'Loughlin, Y. Cheng, A. Mortazavi, A. A. McDonald, P. Kunapuli, et al. Arsenic Trioxide Affects Signal Transducer and Activator of Transcription Proteins through Alteration of Protein Tyrosine Kinase Phosphorylation. Clin. Cancer Res., November 15, 2006; 12(22): 6817 - 6825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. S. Nagy, H. Rui, S. M. Stepkowski, J. Karras, and R. A. Kirken A Preferential Role for STAT5, not Constitutively Active STAT3, in Promoting Survival of a Human Lymphoid Tumor J. Immunol., October 15, 2006; 177(8): 5032 - 5040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Han, H. M. Amin, B. Franko, C. Frantz, X. Shi, and R. Lai Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma Blood, October 15, 2006; 108(8): 2796 - 2803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ye, N. Wolff, L. Li, S. Zhang, and R. L. Ilaria Jr STAT5 signaling is required for the efficient induction and maintenance of CML in mice Blood, June 15, 2006; 107(12): 4917 - 4925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. J. Wierenga, H. Schepers, M. A. S. Moore, E. Vellenga, and J. J. Schuringa STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBP{alpha} Blood, June 1, 2006; 107(11): 4326 - 4333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Hickey and T. G. Cotter BCR-ABL Regulates Phosphatidylinositol 3-Kinase-p110{gamma} Transcription and Activation and Is Required for Proliferation and Drug Resistance J. Biol. Chem., February 3, 2006; 281(5): 2441 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, R. A. Kirken, L. Furian, S. Janczewska, X. Qu, W. W. Hancock, M. Wang, N. Tejpal, R. Kerman, B. D. Kahan, et al. Allograft Rejection Requires STAT5a/b-Regulated Antiapoptotic Activity in T Cells but Not B Cells J. Immunol., January 1, 2006; 176(1): 128 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Boggon, Y. Li, P. W. Manley, and M. J. Eck Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog Blood, August 1, 2005; 106(3): 996 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Hickey, K. England, and T. G. Cotter Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK J. Leukoc. Biol., July 1, 2005; 78(1): 289 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Gu, L. Santiago, and B. S. Mitchell Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl Blood, April 15, 2005; 105(8): 3270 - 3277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Moucadel and S. N. Constantinescu Differential STAT5 Signaling by Ligand-dependent and Constitutively Active Cytokine Receptors J. Biol. Chem., April 8, 2005; 280(14): 13364 - 13373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Schuringa, K. Y. Chung, G. Morrone, and M. A.S. Moore Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation J. Exp. Med., September 7, 2004; 200(5): 623 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lai, G. Z. Rassidakis, L. J. Medeiros, L. Ramdas, A. H. Goy, C. Cutler, Y. Fujio, K. Kunisada, H. M. Amin, and F. Gilles Signal Transducer and Activator of Transcription-3 Activation Contributes to High Tissue Inhibitor of Metalloproteinase-1 Expression in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Am. J. Pathol., June 1, 2004; 164(6): 2251 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Calabretta and D. Perrotti The biology of CML blast crisis Blood, June 1, 2004; 103(11): 4010 - 4022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gate, R. S. Majumdar, A. Lunk, and K. D. Tew Increased Myeloproliferation in Glutathione S-Transferase {pi}-deficient Mice Is Associated with a Deregulation of JNK and Janus Kinase/STAT Pathways J. Biol. Chem., March 5, 2004; 279(10): 8608 - 8616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Behbod, Z. S. Nagy, S. M. Stepkowski, J. Karras, C. R. Johnson, W. D. Jarvis, and R. A. Kirken Specific Inhibition of Stat5a/b Promotes Apoptosis of IL-2-Responsive Primary and Tumor-Derived Lymphoid Cells J. Immunol., October 15, 2003; 171(8): 3919 - 3927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu, Y. Ma, S. M. Cole, C. Zander, K.-H. Chen, J. Karras, and R. M. Pope Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival Blood, July 1, 2003; 102(1): 344 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Sexl, B. Kovacic, R. Piekorz, R. Moriggl, D. Stoiber, A. Hoffmeyer, R. Liebminger, O. Kudlacek, E. Weisz, K. Rothammer, et al. Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation Blood, June 15, 2003; 101(12): 4937 - 4943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Sriuranpong, J. I. Park, P. Amornphimoltham, V. Patel, B. D. Nelkin, and J. S. Gutkind Epidermal Growth Factor Receptor-independent Constitutive Activation of STAT3 in Head and Neck Squamous Cell Carcinoma Is Mediated by the Autocrine/Paracrine Stimulation of the Interleukin 6/gp130 Cytokine System Cancer Res., June 1, 2003; 63(11): 2948 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Chiorean, S. J. Dylla, K. Olsen, T. Lenvik, Y. Soignier, and J. S. Miller BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs) Blood, May 1, 2003; 101(9): 3527 - 3533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler Signal transducer and activator of transcription proteins in leukemias Blood, April 15, 2003; 101(8): 2940 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Golas, K. Arndt, C. Etienne, J. Lucas, D. Nardin, J. Gibbons, P. Frost, F. Ye, D. H. Boschelli, and F. Boschelli SKI-606, a 4-Anilino-3-quinolinecarbonitrile Dual Inhibitor of Src and Abl Kinases, Is a Potent Antiproliferative Agent against Chronic Myelogenous Leukemia Cells in Culture and Causes Regression of K562 Xenografts in Nude Mice Cancer Res., January 15, 2003; 63(2): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zheng, A. D. Friedman, and D. Small Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations Blood, December 1, 2002; 100(12): 4154 - 4161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Burdelya, R. Catlett-Falcone, A. Levitzki, F. Cheng, L. B. Mora, E. Sotomayor, D. Coppola, J. Sun, S. Sebti, W. S. Dalton, et al. Combination Therapy with AG-490 and Interleukin 12 Achieves Greater Antitumor Effects than Either Agent Alone Mol. Cancer Ther., September 1, 2002; 1(11): 893 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. List, K. J. Kopecky, C. L. Willman, D. R. Head, M. L. Slovak, D. Douer, S. R. Dakhil, and F. R. Appelbaum Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase Blood, August 13, 2002; 100(5): 1910 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oki, A. Limnander, N. N. Danial, and P. B. Rothman Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells Blood, July 18, 2002; 100(3): 966 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Wolff and R. L. Ilaria Jr Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571 Blood, November 1, 2001; 98(9): 2808 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kube, U. Holtick, M. Vockerodt, T. Ahmadi, B. Haier, I. Behrmann, P. C. Heinrich, V. Diehl, and H. Tesch STAT3 is constitutively activated in Hodgkin cell lines Blood, August 1, 2001; 98(3): 762 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Q. Ning, J. Li, and R. J. Arceci Signal transducer and activator of transcription 3 activation is required for Asp816 mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells Blood, June 1, 2001; 97(11): 3559 - 3567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Frantsve, J. Schwaller, D. W. Sternberg, J. Kutok, and D. G. Gilliland Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation Mol. Cell. Biol., May 15, 2001; 21(10): 3547 - 3557. [Abstract] [Full Text]
|
|
|
|
|
|
G. Niu, K. H. Shain, M. Huang, R. Ravi, A. Bedi, W. S. Dalton, R. Jove, and H. Yu Overexpression of a Dominant-Negative Signal Transducer and Activator of Transcription 3 Variant in Tumor Cells Leads to Production of SolubleFactors That Induce Apoptosis and Cell Cycle Arrest Cancer Res., April 1, 2001; 61(8): 3276 - 3280. [Abstract] [Full Text]
|
|
|
|
|
|
E. Laurent, M. Talpaz, H. Kantarjian, and R. Kurzrock The BCR Gene and Philadelphia Chromosome-positive Leukemogenesis Cancer Res., March 1, 2001; 61(6): 2343 - 2355. [Full Text]
|
|
|
|
|
|
M. H. Tomasson, I. R. Williams, S. Li, J. Kutok, D. Cain, S. Gillessen, G. Dranoff, R. A. Van Etten, and D. G. Gilliland Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3 Blood, March 1, 2001; 97(5): 1435 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Holyoake, X. Jiang, H. G. Jorgensen, S. Graham, M. J. Alcorn, C. Laird, A. C. Eaves, and C. J. Eaves Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3 Blood, February 1, 2001; 97(3): 720 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Kazansky and J. M. Rosen Signal Transducers and Activators of Transcription 5B Potentiates v-Src-mediated Transformation of NIH-3T3 Cells Cell Growth Differ., January 1, 2001; 12(1): 1 - 7. [Abstract] [Full Text]
|
|
|
|
|
|
C. L. Campbell, Z. Jiang, D. M. F. Savarese, and T. M. Savarese Increased Expression of the Interleukin-11 Receptor and Evidence of STAT3 Activation in Prostate Carcinoma Am. J. Pathol., January 1, 2001; 158(1): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. N. Deininger, J. M. Goldman, and J. V. Melo The molecular biology of chronic myeloid leukemia Blood, November 15, 2000; 96(10): 3343 - 3356. [Full Text] [PDF]
|
|
|
|
|
|
R. Rawat, G. J. Rainey, C. D. Thompson, M. R. Frazier-Jessen, R. T. Brown, and R. P. Nordan Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas Blood, November 15, 2000; 96(10): 3514 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kirken, R. A. Erwin, L. Wang, Y. Wang, H. Rui, and W. L. Farrar Functional Uncoupling of the Janus Kinase 3-Stat5 Pathway in Malignant Growth of Human T Cell Leukemia Virus Type 1-Transformed Human T Cells J. Immunol., November 1, 2000; 165(9): 5097 - 5104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Di Bacco, K. Keeshan, S. L. McKenna, and T. G. Cotter Molecular Abnormalities in Chronic Myeloid Leukemia: Deregulation of Cell Growth and Apoptosis Oncologist, October 1, 2000; 5(5): 405 - 415. [Abstract] [Full Text]
|
|
|
|
|
|
V. Sexl, R. Piekorz, R. Moriggl, J. Rohrer, M. P. Brown, K. D. Bunting, K. Rothammer, M. F. Roussel, and J. N. Ihle Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of Stat5 Blood, September 15, 2000; 96(6): 2277 - 2283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Oetzel, T. Jonuleit, A. Götz, H. van der Kuip, H. Michels, J. Duyster, M. Hallek, and W. E. Aulitzky The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-positive Cells by Down-Regulating BCL-X Clin. Cancer Res., May 1, 2000; 6(5): 1958 - 1968. [Abstract] [Full Text]
|
|
|
|
|
|
M. Horita, E. J. Andreu, A. Benito, C. Arbona, C. Sanz, I. Benet, F. Prosper, and J. L. Fernandez-Luna Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5-dependent Expression of Bcl-xL J. Exp. Med., March 13, 2000; 191(6): 977 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Ward, I. Touw, and A. Yoshimura The Jak-Stat pathway in normal and perturbed hematopoiesis Blood, January 1, 2000; 95(1): 19 - 29. [Full Text] [PDF]
|
|
|
|
|
|
J. Turkson, T. Bowman, J. Adnane, Y. Zhang, J. Y. Djeu, M. Sekharam, D. A. Frank, L. B. Holzman, J. Wu, S. Sebti, et al. Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein Mol. Cell. Biol., November 1, 1999; 19(11): 7519 - 7528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Jiang, A. Lopez, T. Holyoake, A. Eaves, and C. Eaves Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia PNAS, October 26, 1999; 96(22): 12804 - 12809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Gross, X. Zhang, and R. Ren Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy Mol. Cell. Biol., October 1, 1999; 19(10): 6918 - 6928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Niu, R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, W. Dalton, R. Jove, and H. Yu Gene Therapy with Dominant-negative Stat3 Suppresses Growth of the Murine Melanoma B16 Tumor in Vivo Cancer Res., October 1, 1999; 59(20): 5059 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. de Groot, J. A.M. Raaijmakers, J.-W. J. Lammers, R. Jove, and L. Koenderman STAT5 Activation by BCR-Abl Contributes to Transformation of K562 Leukemia Cells Blood, August 1, 1999; 94(3): 1108 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zou and K. Calame Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase J. Biol. Chem., June 25, 1999; 274(26): 18141 - 18144. [Full Text] [PDF]
|
|
|
|
|
|
J. M.-Y. Ho, B. K. Beattie, J. A. Squire, D. A. Frank, and D. L. Barber Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling Blood, June 15, 1999; 93(12): 4354 - 4364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nieborowska-Skorska, M. A. Wasik, A. Slupianek, P. Salomoni, T. Kitamura, B. Calabretta, and T. Skorski Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis J. Exp. Med., April 19, 1999; 189(8): 1229 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H.A. Hermans, C. Antonissen, A. C. Ward, A. E.M. Mayen, R. E. Ploemacher, and I. P. Touw Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia-derived Mutation in the G-CSF Receptor Gene J. Exp. Med., February 15, 1999; 189(4): 683 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Ward, Y. M. van Aesch, A. M. Schelen, and I. P. Touw Defective Internalization and Sustained Activation of Truncated Granulocyte Colony-Stimulating Factor Receptor Found in Severe Congenital Neutropenia/Acute Myeloid Leukemia Blood, January 15, 1999; 93(2): 447 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
